GGrantIndex
Sort

8,912 grants matching sars cov 2

Phylogenetic modeling of viral transmission dynamics at the human-wildlife interface in Uganda

$667,311
Krista Milich · Washington University · R01 · FY2024 · TW

Development and characterization of engineered therapeutic antibodies against SARS-CoV-2

$667,277
Gaya K. Amarasinghe · Washington University · R01 · FY2021 · AI

MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 THERAPEUTICS RESEARCH RELATED ACTIVITIES

$667,054
Timothy Stedman · American Type Culture Collection · N01 · FY2021 · AI

Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis

$666,810
James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK

Understanding the Risk of Bat Coronavirus Emergence

$666,442
Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2014 · AI

Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources

$666,327
Yuedong Wang · University Of California Santa Barbara · R01 · FY2023 · DK

Administrative Core

$666,251
Clifford J Rosen · Mainehealth · U54 · FY2023 · GM

COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.

$665,975
John A Dodson · New York University School Of Medicine · R01 · FY2024 · AG

When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States

$665,811
Becky Lynn Genberg · Johns Hopkins University · R01 · FY2020 · DA

Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients

$665,800
Mario C. Deng · University Of California Los Angeles · R01 · FY2022 · AI

Heat Therapy for the treatment of post-acute COVID-19 syndrome

$665,766
Gwenael Layec · University Of Nebraska Omaha · R01 · FY2024 · AG

Stanford MoTrPAC Bioinformatics Center

$665,425
Euan A Ashley · Stanford University · U24 · FY2020 · OD

Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip

$665,322
John H Connor · Boston University Medical Campus · R01 · FY2022 · HL

Quantifying Error Growth to Improve Infectious Disease Forecast Accuracy

$665,285
Jeffrey L Shaman · Columbia University Health Sciences · R01 · FY2021 · AI

Remote homology detection with evolutionary profile HMMs

$665,188
Elena Rivas · Harvard University · · FY2022 · BIO

Covid-19 Effects on Children & Families: 2021 Follow-Up of the PSID Child Development Supplement

$665,025
Narayan Sastry · University Of Michigan At Ann Arbor · R01 · FY2022 · HD

Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASC

$664,976
Michael Joseph Peluso · University Of California, San Francisco · R01 · FY2024 · NS

Pathogenesis and Outcomes of SARS-CoV-2 In Utero Transmission - Immunologic and Virologic Evaluations

$664,837
Andrea A. Kovacs · University Of Southern California · R56 · FY2024 · AI

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$664,782
Yang Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI

Functional Role of HIF-PHDs in ARDS

$664,541
Holger K. Eltzschig · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · HL

A universal intranasal nanoengineered therapy against airborne RNA viruses

$664,392
Vinay Subhash Mahajan · Brigham And Women'S Hospital · R01 · FY2025 · EB

A universal intranasal nanoengineered therapy against airborne RNA viruses

$664,392
Vinay Subhash Mahajan · Brigham And Women'S Hospital · R01 · FY2024 · EB

Covid-19 Effects on Children & Families: 2021 Follow-Up of the PSID Child Development Supplement

$663,689
Narayan Sastry · University Of Michigan At Ann Arbor · R01 · FY2024 · HD

COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling

$663,601
Harvey B Pollard · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2023 · HL

Human Mitochondrial Dna Polymerase With Anti-hiv Nucleotides

$663,534
William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES